Company: RDPTF
Filing Date: 2025-09-18
Form Type: 20-F
Source: 0001213900-25-088699
Chunk: 2

Company: Radiopharm Theranostics Ltd
Filing Date: 2025-09-18
Form: 20-F
Item: Item 3
Chunk 2
---
  which may negatively affect our future profitability.  
 ─────────────────────────────────────────────────────────

Risks Relating to Ownership of the ADS

  The trading price of the ADSs may be volatile,              
  and purchasers of the ADSs could incur substantial losses.  
 ──────────────────────────────────────────────────────────────

  If we are or become a passive foreign investment                                         

  The requirements of being a public company may           
  strain our resources and divert management’s attention.  
 ───────────────────────────────────────────────────────────

  We could become subject to the auditor attestation                                                                                       

  Our issuance of additional ordinary shares in                                                           

  As long as we remain subject to the rules of                                                                                              
  the ASX, we may be unable to conduct certain types of capital raisings without shareholder approval if such capital raising would result  
  in an equity issuance above regulatory thresholds and, consequently, we could be unable to obtain financing sufficient to sustain our     
  business if we are unsuccessful in soliciting requisite shareholder approvals.                                                            
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  We are subject to risks associated with currency                                                      
  fluctuations, and changes in foreign currency exchange rates could impact our results of operations.  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────

  Our ADS holders are not shareholders and do not  

  Our ADS holders do not have the same rights to                 

  There are circumstances where it may be unlawful                  
  or impractical to make distributions to the holders of our ADSs.  
 ────────────────────────────────────────────────────────────────────

  ADS holders may not be entitled to a jury trial                                                                                               
  with respect to claims arising under the deposit agreement, which could augur less favorable results to the plaintiff(s) in any such action.  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  The exclusive jurisdiction and arbitration provided                                                           
  for in the deposit agreement may discourage claims or limit the ability of the ADS holders to bring a claim.  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────

Risks Relating to Our Location In Australia

  Australian takeover laws may discourage takeover                                            
  offers being made for us or may discourage the acquisition of large numbers of our shares.  
 ─────────────────────────────────────────────────────────────────────────────────────────────